They may recommend adjustments to your weight loss plan or medications to support bile flow and reduce the risk of gallstones
Semaglutide directly targets the estrogen-related loss of GLP-1 receptor sensitivity that drives menopausal appetite dysregulation
Available from: The Lancet GLP-1 Medications May Lower Dementia Risk, Research Suggests. JAMA
Weight loss drugs, on the other hand, are not a magic bullet and should be used along with a healthy diet and exercise
In a study published in May, researchers used a large patient dataset to compare the NAION rate within 1 year of adults with Type 2 diabetes starting GLP-1 treatment (like Ozempic) versus those starting dipeptidyl peptidase 4 inhibitors
Through continued research, patient engagement, and personalized care strategies, the full potential of Semaglutide can be realized, offering patients a path to better health with minimal discomfort